Employment Agreement



 EXHIBIT 10.25 
 EMPLOYMENT AGREEMENT 
 THIS AGREEMENT by and among APP Pharmaceuticals, Inc., a Delaware
corporation (the “Company”), Christopher Bryant (the “Executive”) and, solely for the purposes of guaranteeing the Company’s obligations under Section 5 of this Agreement, Fresenius SE, a societas
europaea, organized under the laws of Germany (the “Parent”) is dated May 15, 2009; 
 WHEREAS, on September 10, 2008,
the Company became an indirect subsidiary of the Parent; 
 WHEREAS, the Company desires to have the Executive serve as the Company’s
Chief Scientific Officer, on the terms and conditions set forth in this Agreement; 
 WHEREAS, the Executive desires to accept such service,
subject to the terms and conditions of this Agreement. 
 NOW, THEREFORE, in consideration of the premises and mutual covenants contained
herein and for other good and valuable consideration, the receipt and sufficiency of which is mutually acknowledged, the Company and the Executive (individually, a “Party” and together, the “Parties”) agree as
follows: 
  

	 	1.	Effective Date. The “Effective Date” shall mean May 15, 2009. 

  

	 	2.	Employment Period. The Company hereby agrees to employ the Executive, and the Executive hereby agrees to be employed by the Company, subject to the terms and conditions of
this Agreement, for a period commencing on the Effective Date and ending on December 31, 2011, unless earlier terminated as provided herein. Notwithstanding the foregoing, commencing on January 1, 2012 and each January 1 thereafter
(each, an “Extension Effective Date”), the term of this Agreement shall be extended, without further action by the Company or the Executive, for successive periods of twelve months each, unless either Party shall have given three
(3) months’ advance notice to the other Party, in the manner set forth in Section 8(b) below, prior to the Extension Effective Date in question, that the term of this Agreement that is in effect at the time such notice is given is not
to be extended or further extended, as the case may be (the period of such employment to be called the “Employment Period”). 

  

	 	3.	Terms of Employment. 

  

	 	(a)	Position and Duties. 

  

	 	(i)	During the Employment Period, the Executive shall serve as the Chief Scientific Officer of the Company, with such duties and responsibilities as are commensurate with such position,
and shall report directly to the Chief Executive Officer of the Company. The Executive’s principal location of employment shall be at the principal headquarters of the Company in Schaumburg, Illinois; provided, however, that the
Executive may be required under reasonable business circumstances to travel outside of the principal location of employment in connection with performing his duties under this Agreement. 

  

 1 









	 	(ii)	The Executive agrees that during the Employment Period, he shall devote all of his business time, energies and talents to serving as the Company’s Chief Scientific Officer, and
shall perform his duties conscientiously and faithfully subject to the lawful directions of the Chief Executive Officer of the Company, and in accordance with each of the corporate governance and ethics guidelines, conflict of interests policies,
and codes of conduct of the Company. 

  

	 	(iii)	During the Employment Period, the Executive shall not, without the prior written consent of the Chief Executive Officer of the Company: (A) render or perform services of a
business, professional or commercial nature other than to or for the Company or any of its affiliates or subsidiaries, either alone or as an employee, consultant, director, officer or partner of another business entity (including serving on boards
of directors), whether or not for compensation or (B) plan or otherwise take any preliminary steps, either alone or in concert with others, to establish or engage in any business activity that would compete with the current or proposed
businesses of the Company or any of its affiliates or subsidiaries. 

  

	 	(b)	Compensation. 

  

	 	(i)	Base Salary. As compensation for the performance by the Executive of his obligations hereunder, during the Employment Period, the Company shall pay the Executive a base
salary at an annual rate of $300,000 (the “Base Salary”). The Base Salary shall be payable in accordance with the Company’s regularly established payroll practice. The Company shall conduct an annual review of the Base Salary
and may increase or decrease such Base Salary in its sole discretion, based on the performance of the Executive and the Company. 

  

	 	(ii)	Annual Bonus. With respect to each calendar year during the Employment Period including 2009, the Executive shall be eligible to receive a cash bonus of up to fifty percent
(50%) of Base Salary, based on the achievement of the Company targets and Executive’s functional business unit objectives (“Annual Bonus”). Fifty percent (50%) of Executive’s bonus target will be based on achievement of
the Company revenue and earnings targets, established by Company goals, and fifty percent (50%) will be based upon Executive’s achievement of the goals for new product development and deliveries as agreed upon in Executive’s approved
functional business unit objectives. The Annual Bonus will be payable in a single lump sum cash payment not later than March 15 following the conclusion of the calendar year in which the Annual Bonus is earned. The Bonus payment for the
calendar year 2009 will be prorated per the Company Management Bonus plan 

  

	 	(iii)	Vacation. During the Employment Period, the Executive shall be entitled to four (4) weeks of paid vacation for each calendar year or ratable part thereof. In addition,
the Executive shall be entitled to all paid holidays typically granted to executive officers of the Company generally. 

  

 2 









	 	(iv)	Benefits and Perquisites. The Executive shall be entitled to participate on a comparable basis in all employee benefit plans and to all perquisites which shall be made
available from time to time to executive officers of the Company generally (including, but not limited to equity-based and other long-term incentive plans, qualified and non-qualified retirement and deferred compensation plans, medical, dental and
other welfare plans, and executive short-term disability insurance, and executive long-term disability insurance and supplemental income protection, health club reimbursement, estate and financial planning services and supplemental life insurance).
The Executive acknowledges and agrees that the Company may, in its discretion, terminate at any time or modify from time to time any such employee benefit plans or perquisites. 

  

	 	(v)	Company Automobile Lease. The Executive shall be entitled to an automobile lease allowance during the Employment Period at the Company’s expense in an amount not to
exceed $1,000 per month. 

  

	 	(vi)	Expenses. During the Employment Period, the Executive shall be eligible for prompt reimbursement for business expenses reasonably incurred by the Executive in accordance with
the policies of the Company as may be in effect from time to time for executive officers of the Company generally. 

  

	 	4.	Termination of Employment. 

  

	 	(a)	Death. The Executive’s employment shall terminate automatically upon the Executive’s death during the Employment Period. 

  

	 	(b)	Disability. If the Executive experiences a Disability (within the meaning of the applicable disability plan, program or arrangement of the Company, as in effect from time to
time) during the Employment Period, the Company may provide the Executive with a Notice of Termination in accordance with Section 4(f) below of its intention to terminate the Executive’s employment. In such event, the Executive’s
employment with the Company shall terminate immediately upon the receipt of such Notice of Termination by the Executive. 

  

	 	(c)	Cause. The Executive’s employment may be terminated by the Company during the Employment Period other than for Cause upon the Company providing a Notice of Termination
to the Executive of its intention to so terminate the Executive’s employment in accordance with Section 4(f) below. The Executive’s employment may be terminated by the Company for Cause if (A) the Company provides the Executive
with a Notice of Termination in accordance with Section 4(f) of this Agreement within 30 days after the initial occurrence or existence of an event or circumstance set forth in this Section 4(c), which notice shall specifically identify
the event or circumstance that the Company believes constitutes Cause and (B) the Executive fails to correct the circumstance or event so identified within 60 days after the receipt of such notice. For purposes of this Agreement,
“Cause” shall mean: 

  

 3 









	 	(i)	the Executive’s dishonesty, willful misconduct or gross negligence in the performance of his duties to the Company or any of its affiliates or subsidiaries;


  

	 	(ii)	the Executive’s willful material misrepresentation at any time to the Company or any of its affiliates or subsidiaries; 

  

	 	(iii)	the Executive’s intentional failure or refusal to perform his reasonably assigned duties; 

  

	 	(iv)	the Executive’s commission of any felony, or any other crime (whether or not a felony) involving dishonesty, fraud or breach of trust; 

  

	 	(v)	the Executive’s willful or grossly negligent failure to comply with any written rules, regulations, policies or procedures of the Company or any of its affiliates or
subsidiaries; or 

  

	 	(vi)	the Executive’s material breach of the provisions of Section 6 of this Agreement. 

  

	 	(d)	Good Reason. The Executive’s employment may be voluntarily terminated by the Executive with Good Reason if (A) an event or circumstance set forth in the clauses of
this Section 4(d) below shall have occurred and the Executive provides the Company with a Notice of Termination in accordance with Section 4(f) below within 30 days after the Executive has knowledge of the initial occurrence or existence
of such event or circumstance, which notice shall specifically identify the event or circumstance that the Executive believes constitutes Good Reason and (B) the Company fails to correct the circumstance or event so identified within 90 days
after the receipt of such notice. For purposes of this Agreement, “Good Reason” shall mean, without the Executive’s express written consent, the occurrence of any of the following circumstances: 

  

	 	(i)	There is a reduction in the Executive’s status or responsibilities which represents a material and adverse change from the Executive’s overall status or responsibilities,
taken as a whole, in reference to the status or responsibilities contemplated by Section 3(a); 

  

	 	(ii)	The Executive is required to be based at any place outside of fifty (50) mile radius from Schaumburg, Illinois without his written consent, except for travel that is reasonably
necessary in connection with the Company’s business; 

  

	 	(iii)	Any material breach of the Agreement by the Company, including but not limited to, the failure to pay or provide compensation and benefits in accordance with Section 3
(b) hereof; 

  

	 	(iv)	Delivery by the Company of a notice of non-extension pursuant to Section 2; or 

  

	 	(v)	Any failure by the Successor to assume and agree to perform the Company’s obligations hereunder. 

  

 4 









	 	(e)	Voluntary Termination. The Executive may voluntarily terminate his employment under this Agreement without Good Reason upon the Executive providing a Notice of Termination to
the Company of his intention to so terminate his employment in accordance with Section 4(f) below and such termination shall not be deemed to be a breach of this Agreement. 

  

	 	(f)	Notice of Termination. Any termination of the Executive’s employment by the Company or by the Executive (other than death) shall be communicated by a written notice
(“Notice of Termination”) to the other Party hereto in accordance with Section 8(b) below. The “Date of Termination” shall mean (i) if the Executive’s employment is terminated by the Executive’s
death, the date of his death, (ii) if the Executive’s employment is terminated by the Company for Cause or Disability, the date specified in the Notice of Termination and (iii) if the Executive’s employment is terminated under
any circumstances other than those described in clause (i) or (ii) immediately preceding, the date specified in the Notice of Termination which shall not be less than 90 days from the date such Notice of Termination is given.


  

	 	(g)	Resignation from All Positions. Notwithstanding any other provision of this Agreement, upon the termination of the Executive’s employment for any reason, unless
otherwise requested by the Company, the Executive shall immediately resign from all positions that he holds or has ever held with the Company or any of its affiliates or subsidiaries (and with any other entities with respect to which the Company has
requested the Executive to perform services). The Executive hereby agrees to execute any and all documentation to effectuate such resignations upon request by the Company, but he shall be treated for all purposes as having so resigned upon the Date
of Termination, regardless of when or whether he executes any such documentation. 

  

	 	5.	Obligations of the Company upon Termination. 

  

	 	(a)	Good Reason; Other Than for Cause. If during the Employment Period, (A) the Company shall terminate the Executive’s employment other than for Cause, death or
Disability or (B) the Executive shall terminate employment with Good Reason: 

  

	 	(i)	the Company shall pay to the Executive within 30 days after the Date of Termination the sum of (1) the Executive’s accrued but unpaid Base Salary and any accrued but
unpaid Annual Bonus through the Date of Termination and the Executive’s business expenses that are reimbursable pursuant to Section 3(b)(vi) but have not yet been reimbursed by the Company as of the Date of Termination (collectively, the
“Obligations”); 

  

	 	(ii)	the Company shall pay to the Executive an amount equal to the sum of (A) 1.5 times the Executive’s then-current Base Salary at the highest rate in effect during the 12
– month period immediately preceding the Date of Termination and (B) 30% of the Annual Bonus paid or payable to the Executive for the most recently completed calendar year, payable in substantially equal installments in accordance with the
Company’s regularly established payroll practice during the twelve (12) month period following immediately the Date of Termination; 

  

 5 









	 	(iii)	the Company shall continue to provide the benefits (Health and Dental Insurance only) to the Executive set forth in Section 3(b)(iv) above during the twelve (12) month
period following the Date of Termination; and 

  

	 	(iv)	Except with respect to payments and benefits under Sections 5(a)(i), all payments and benefits to be provided under this Section 5(a) shall be subject to the Executive’s
execution and non-revocation of a general release of claims in favor of the Company and its affiliates and subsidiaries. 

  

	 	(b)	Cause; Other than for Good Reason. If the Executive’s employment shall be terminated for Cause or if the Executive terminates his employment without Good Reason during
the Employment Period, this Agreement shall terminate without further obligations to the Executive, other than the obligation to pay or provide to the Executive the Obligations and the timely payment or provision of the Other Benefits.


  

	 	(c)	Death. If the Executive’s employment is terminated by reason of the Executive’s death during the Employment Period, this Agreement shall terminate without further
obligations to the Executive’s legal representatives, other than the obligation to pay or provide to the Executive’s beneficiaries the Obligations and the timely payment or provision of the Other Benefits. 

  

	 	(d)	Disability. If the Executive’s employment is terminated by reason of the Executive’s Disability during the Employment Period, this Agreement shall terminate without
further obligations to the Executive, other than the obligation to pay or provide to the Executive the Obligations and the timely payment or provision of the Other Benefits, including any applicable disability benefits. 

  

	 	6.	Unauthorized Disclosure; Non-Solicitation; Non-Competition; Proprietary Rights. 

  


	 	(a)	 Unauthorized Disclosure. The Executive agrees and understands that in the Executive’s position with the Company, the Executive has been and will be
exposed to and has and will receive information relating to the confidential affairs of the Company, including, without limitation, technical information, intellectual property, business and marketing plans, strategies, customer information,
software, other information concerning the products, promotions, development, financing, expansion plans, business policies and practices of the Company and other forms of information considered by the Company to be confidential and in the nature of
trade secrets (including, without limitation, ideas, research and development, know-how, formulas, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information and business and marketing plans and
proposals) (collectively, the “Confidential Information”); provided, however, that information that is or becomes generally available to the public other than as a result of a breach of this Agreement by the Executive
shall not be considered to be Confidential Information. The Executive agrees that at all times during the Executive’s employment with the Company and thereafter, the Executive shall not disclose such Confidential Information, either directly or
indirectly, to any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof (each, a
“Person”) without the prior written consent of the 



  

 6 








 
Company and shall not use or attempt to use any such information in any manner other than in connection with his employment with the Company, unless required
by law to disclose such information, in which case the Executive shall provide the Company with written notice in accordance with Section 8(b) below of such requirement as far in advance of such anticipated disclosure as possible so as to
enable the Company to seek an appropriate protective order or confidential treatment. This confidentiality covenant has no temporal, geographical or territorial restriction. Upon termination of the Executive’s employment with the Company, the
Executive shall promptly supply to the Company all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs, machines, technical data and any other tangible product
or document which has been produced by, received by or otherwise submitted to the Executive during or prior to the Executive’s employment with the Company, and any copies thereof in his (or capable of being reduced to his) possession.

  

	 	(b)	Non-Competition. By and in consideration of the Company’s entering into this Agreement and the payments to be made and benefits to be provided by the Company hereunder,
and in further consideration of the Executive’s exposure to the Confidential Information of the Company, the Executive agrees that the Executive shall not, during the Executive’s employment with the Company and for a twelve-month period
following the Date of Termination (the “Restriction Period”), directly or indirectly, own, manage, operate, join, control, be employed by, or participate in the ownership, management, operation or control of, or be connected in any
manner with, including, without limitation, holding any position as a stockholder, director, officer, consultant, independent contractor, employee, partner, or investor in, any Restricted Enterprise (as defined below); provided,
however, that in no event (A) shall ownership by the Executive of five percent (5%) or less of the outstanding securities of any class of any issuer whose securities are registered under the Securities Exchange Act of 1934, as
amended, standing alone, be prohibited by this Section 6(b), so long as the Executive does not have, or exercise, any rights to manage or operate the business of such issuer other than rights as a stockholder thereof, nor (B) shall being
employed by a Person that is a Restricted Enterprise, standing alone, be prohibited by this Section 6(b), so long as (i) such Person has more than one discrete and readily distinguishable part of its business, (ii) the
Executive’s duties are not at or involving the part of such Person that is the Restricted Enterprise, including, without limitation, serving in a capacity where any Person involved in the Restricted Enterprise reports to the Executive and
(iii) the Executive notifies the Company of employment with such Person prior to commencement of his or her employment with such Person. For purposes of this Section 6(b), “Restricted Enterprise” shall mean any Person that
is engaged, directly or indirectly, in (or intends or proposes to engage in, or has been organized for the purpose of engaging in) the generic injectible pharmaceutical industry and any other businesses the Company engages in or is preparing to
become engaged in, at the time of the Executive’s termination. During the twelve-month period following the Date of Termination, upon the request of the Company, the Executive shall notify the Company of the Executive’s then-current
employment status. 

  

 7 









	 	(c)	Non-Solicitation of Employees. During the Restriction Period, the Executive shall not directly or indirectly contact, induce or solicit (or assist any Person to contact,
induce or solicit) for employment or consulting services any person who is, or within twelve months prior to the date of such solicitation was, an employee or consultant of the Company. 

  

	 	(d)	Non-Solicitation of Customers. During the Restriction Period, the Executive shall not (A) contact, induce or solicit (or assist any Person to contact, induce or solicit)
any Person which has a business relationship with the Company to terminate, curtail or otherwise limit such business relationship, or (B) solicit, other than on behalf of the Company, any Person that the Executive knows or should have known
(i) is a current customer of the Company, (ii) was, within twelve months prior to the date of such solicitation, a customer of the Company or (iii) is a Person with respect to which the Company has, within the twelve months prior to
the date of such solicitation, devoted more than de minimis resources in an effort to cause such Person to become a customer of the Company. 

  

	 	(e)	Proprietary Rights. The Executive shall disclose promptly to the Company any and all inventions, discoveries, and improvements (whether or not patentable or registrable under
copyright or similar statutes), and all patentable or copyrightable works, initiated, conceived, discovered, reduced to practice, or made by him, either alone or in conjunction with others, during the Executive’s employment with the Company and
related to the business or activities of the Company (the “Developments”). Except to the extent any rights in any Developments constitute a work made for hire under the U.S. Copyright Act, 17 U.S.C. § 101 et seq., that are
owned ab initio by the Company, the Executive assigns all of his right, title and interest in and to all Developments (including all intellectual property rights therein) to the Company or its nominee without further compensation, including
all rights or benefits therefor, including without limitation the right to sue and recover for past and future infringement. The Executive acknowledges that any rights in any developments constituting a work made for hire under the U.S. Copyright
Act, 17 U.S.C. § 101 et seq., are owned upon creation by the Company as the Executive’s employer. Whenever requested to do so by the Company, the Executive shall execute any and all applications, assignments or other instruments which the
Company shall deem necessary to apply for and obtain trademarks, patents or copyrights of the United States or any foreign country or otherwise protect the interests of the Company therein. These obligations shall continue beyond the end of the
Executive’s employment with the Company, subject to Section 6(c) hereof, with respect to inventions, discoveries, improvements or copyrightable works initiated, conceived or made by the Executive while employed by the Company, and shall be
binding upon the Executive’s employers, assigns, executors, administrators and other legal representatives. In connection with his execution of this Agreement, the Executive has informed the Company in writing of any interest in any inventions
or intellectual property rights that he holds as of the date hereof. If the Company is unable for any reason, after reasonable effort, to obtain the Executive’s signature on any document needed in connection with the actions described in this
Section 6(d), the Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the Executive’s agent and attorney in fact to act for and in the Executive’s behalf to execute, verify
and file any such documents and to do all other lawfully permitted acts to further the purposes of this section with the same legal force and effect as if executed by the Executive. 

  

 8 









	 	(f)	Remedies. The Executive agrees that any breach of the terms of this Section 6 would result in irreparable injury and damage to the Company for which the Company would
have no adequate remedy at law; the Executive therefore also agrees that in the event of such breach or any threat of breach, the Company shall be entitled to an immediate injunction and restraining order to prevent such breach and/or threatened
breach and/or continued breach by the Executive and/or any and all Persons acting for and/or with the Executive, without having to prove damages, in addition to any other remedies to which the Company may be entitled at law or in equity, including,
without limitation, the obligation of the Executive to return to the Company any portion of severance payments that have been paid to him. The terms of this paragraph shall not prevent the Company from pursuing any other available remedies for any
breach or threatened breach hereof, including, without limitation, the recovery of damages from the Executive. The Executive and the Company further agree that the provisions of the covenants contained in this Section 6 are reasonable and
necessary to protect the businesses of the Company because of the Executive’s access to Confidential Information and his material participation in the operation of such businesses. 

  

	 	(g)	Definition of Company. For purposes of this Section 6, the “Company,” as used above, shall be construed to include the Company and its Parent, subsidiaries and
affiliates. 

  

	 	(h)	Survival. The provisions of this Section 6 shall survive the termination of the Executive’s employment with the Company, regardless of the reason for such
termination, for the duration expressly stated in any such provision or, if no duration is stated, then indefinitely. 

  

	 	7.	Assignment. This Agreement, and the Executive’s rights and obligations hereunder, may not be assigned by the Executive, and any purported assignment by the Executive in
violation hereof shall be null and void. The Company may, without the consent of the Executive, assign this Agreement to any entity that is a successor to (a) all or substantially all of the business and/or assets of the Company or
(b) that portion of the business and/or assets of the Company to which the Executive’s services relate. For purposes of this Agreement, (i) any reference to “the Company” herein shall be deemed to be a reference to any such
successor of the Company and (ii) no transfer of the Executive’s employment that occurs in connection with any event that results in such a successor shall be deemed to be a termination of the Executive’s employment for any purpose
under this Agreement or otherwise. 

  

	 	8.	Miscellaneous. 

  

	 	(a)	Governing Law. This Agreement shall be construed and enforced in accordance with, and the rights and obligations of the parties hereto shall be governed by, the laws of the
state of Illinois, without giving effect to the conflicts of law principles thereof. 

  

 9 









	 	(b)	Notices. All notices, claims, certificates, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given and delivered
if personally delivered or if sent by nationally-recognized overnight courier, by telecopy, or by registered or certified mail, return receipt requested and postage prepaid, addressed as follows: 

 If to the Company, to: 
 APP Pharmaceuticals

 1501 East Woodfield Road 
 Schaumburg, Illinois 60173 
 Attn: Thomas H. Silberg 
 If to the Executive, to the last home address the Company maintains in its records for the Executive 
 Any
such notice or communication shall be deemed to have been received (A) in the case of personal delivery, on the date of such delivery (or if such date is not a business day, on the next business day after the date of delivery), (B) in the
case of nationally-recognized overnight courier, on the next business day after the date sent, (C) in the case of telecopy transmission, when received (or if not sent on a business day, on the next business day after the date sent) and
(D) in the case of mailing, on the third business day following that on which the piece of mail containing such communication is posted. 
  

	 	(c)	Validity; Severability. In the event that any one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason, the
validity, legality and enforceability of the remainder of this Agreement shall not in any way be affected or impaired thereby. Moreover, without limiting the generality of the foregoing, if any one or more of the provisions contained in this
Agreement shall be held to be unreasonable or unenforceable in any respect, including excessively broad as to duration, scope, activity or subject, such provisions shall be construed by limiting and reducing them so as to be enforceable to the
maximum extent allowed by applicable law. 

  

	 	(d)	Amendments and Waivers. This Agreement and any of the provisions hereof may be amended, waived (either generally or in a particular instance and either retroactively or
prospectively), modified or supplemented, in whole or in part, only by written agreement signed by the Parties hereto; provided, however, that the observance of any provision of this Agreement may be waived in writing signed by the
Party that will lose the benefit of such provision as a result of such waiver. The waiver by any Party hereto of a breach of any provision of this Agreement shall not operate or be construed as a further or continuing waiver of such breach or as a
waiver of any other or subsequent breach, except as otherwise specifically provided for in such waiver. Except as otherwise expressly provided herein, no failure on the part of any Party to exercise, and no delay in exercising, any right, power or
remedy hereunder, or otherwise available in respect hereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by such Party preclude any other or further exercise thereof
or the exercise of any right, power or remedy. 

  

 10 









	 	(e)	Cooperation. Following the termination of the Executive’s employment for any reason, the Executive agrees to cooperate with the Company upon the Company’s request
and to be available to the Company with respect to matters arising out of the Executive’s services to the Company at reasonable times and places and upon reasonable notice. The Company shall reimburse the Executive for expenses reasonably
incurred in connection with such matters as agreed by the Executive and the Company in writing. 

  

	 	(f)	Withholding. Notwithstanding any other provision of this Agreement, the Company may withhold from any amounts payable or benefits provided under this Agreement any Federal,
state, and local taxes as shall be required to be withheld pursuant to any applicable law or regulation. 

  

	 	(g)	Waiver; Strict Construction. Subject to the provisions of (Section 8 (d), the Executive’s or the Company’s failure to insist upon strict compliance with any
provision of this Agreement or the failure to assert any right the Executive or the Company may have hereunder, shall not be deemed to be a waiver of such provision or right or any other provision or right of this Agreement.


  

	 	(h)	Entire Agreement; Effect on Prior Agreement. This Agreement shall constitute the entire agreement between the Parties, and shall supersede all prior representations,
agreements and understandings (including any prior course of dealings), both written and oral, between the Parties with respect to the subject matter hereof and thereof. 

  

	 	(i)	Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one
and the same instrument. 

  

	 	(j)	Binding Effect. This Agreement shall inure to the benefit of, and be binding on, the successors and assigns of each of the Parties, including, without limitation, the
Executive’s heirs and the personal representatives of the Executive’s estate and any successor to all or substantially all of the business and/or assets of the Company whether by merger or otherwise (a “Successor”).


  

	 	(k)	No Third Party Beneficiaries. Nothing in this Agreement shall confer upon any Person not a party to this Agreement, or the legal representatives of such Person, any rights or
remedies of any nature or kind whatsoever under or by reason of this Agreement. 

  

	 	9.	 Section 409A. If at the time the Executive becomes entitled to any severance payments or any other termination payment from the Company (collectively
referred to as the “Severance”), the Executive is a “specified employee” (as defined in Section 409A of the Internal Revenue Code of 1986, as amended and the regulations thereunder (“Section 409A”)), then no
Severance considered deferred compensation under Section 409A and not subject to an exception or exemption thereunder shall be paid to the Executive until the date that is six (6) months after the Executive’s date of 



  

 11 








 
termination (or, if later, six (6) months after the Executive has incurred a separation from service as defined in Section 409A). For purposes of
determining whether Severance payment payable on payroll dates occurring on or prior to March 15 of the year following the year that includes the date of termination are exempt from Section 409A as short-term deferrals, each Severance
payment shall be considered a separate payment for purposes of Section 409A. Any Severance that would otherwise have been paid to the Executive during this six-month period that is not exempt from Section 409A shall instead be aggregated
and paid to the Executive on the date that is six (6) months after the Executive’s date of termination. Any Severance to which the Executive is entitled to be paid after the date that is six (6) months following the Executive’s
date of termination or separation from service, as applicable, shall be paid to the Executive in accordance with the applicable schedule. It is intended that this Agreement will comply with Section 409A to the extent applicable, and this
Agreement shall be interpreted and construed on a basis consistent with such intent. The Company and the Executive agree to amend (including retroactively) this Agreement in order to comply with Section 409A, including amending to facilitate
the ability of the Executive to avoid the imposition of, or reduce the amount of, any Section 409A tax or penalties. The Company and the Executive shall reasonably cooperate to provide full effect to this provision and the consent to any
amendment described in the preceding sentence shall not be unreasonably withheld by either party. 
  

	 	10.	Indemnification. The Executive will be covered by the officer and director insurance program of the Fresenius SE group and entitled to indemnification to the fullest extent
under the Amended and Related By-Laws of Fresenius Kabi Pharmaceuticals Holding, Inc. dated September 10, 2008 (or as those by-laws are amended thereafter), Nothing in this Agreement, however, will require the Company to provide indemnification
in any situation where indemnification would violate any applicable law. 

 [Remainder of page intentionally left blank]

  

 12 








 IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and, pursuant to the
authorization from the Board of Management of Fresenius Kabi AG, the Company has caused these presents to be executed in its name and on its behalf, all as of the day and year first above written. 
  

			
	APP PHARMACEUTICALS, INC.
		
	By:	 	Thomas H. Silberg
		 	Name: Thomas H. Silberg
		 	Title: President/CEO


  

	
	Agreed and Accepted:
	
	/s/ Christopher Bryant
	Christopher Bryant

  

 13